// App-Quantinova.ai

211 : The prognostic value of stroma desmoplasia in pancreatic ductal adenocarcinoma.

Researchers

Presenter

  • Emmanouil Fokas

Principal Investigators

  • Michael A Silva

  • Zenobia D'Costa

  • Robin Bockelmann

  • Zahir Soonawalla

  • Stanley K. Liu

  • Eric O'Neill

  • Somnath Mukherjee

  • William Gillies McKenna

  • Ruth J Muschel

  • Lai Mun Wang

Medical Centers

  • CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, United Kingdom

  • Nuffield Department of Medicine, Oxford University Hospital NHS Trust, Oxford, United Kingdom

  • Department of Oncology, CRUK/MRC Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • University of Oxford, Oxford, United Kingdom

  • Department of Pathology, Oxford University Hospital NHS Trust, University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A